Jonathan H. Kaufman - 21 Jan 2025 SCHEDULE 13D/A Report for Lipella Pharmaceuticals Inc. Common Stock, par value $0.0001 per share (LIPO)

Filing Manager: Jonathan H. Kaufman
Reporting Manager: Jonathan H. Kaufman
Security: Lipella Pharmaceuticals Inc. Common Stock, par value $0.0001 per share
Symbol: LIPO
Shares outstanding: 1,814,436 shares
Disclosed Ownership: 212,289 shares
Ownership: 12%
Form type: SCHEDULE 13D/A
Filing time: 23 Jan 2025, 18:08:21 UTC
Date of event: 21 Jan 2025
Previous filing: 17 Jan 2025
Next filing: 30 Jan 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Jonathan H. Kaufman	12%	212,289	212,289	0	/s/ Jonathan H. Kaufman	Jonathan H. Kaufman	0001959250